Florian Eichler, MD

Assistant professor of neurology, Harvard Medical School, and director, leukodystrophy service, Massachusetts General Hospital.

Articles by Florian Eichler, MD

Florian Eichler, MD, on Addressing Unmet Needs in Canavan Disease With Gene Therapy

ByFlorian Eichler, MD

May 20th 2023

The neurologist at Massachusetts General Hospital discussed BBP-812, an investigational AAV vector-based gene therapy being evaluated for Canavan disease in a phase 1/2 trial.

Florian Eichler, MD, on Promising Efficacy of AXO-AAV-GM2 in GM2 Gangliosidosis

ByFlorian Eichler, MD

May 20th 2022

The director of the leukodystrophy service at Mass Gen discussed progress dosing in the phase 1/2 trial.

Florian Eichler, MD, on How Novel Gene Therapy Delivery Improved Targeting in GM2 Gangliosidosis

ByFlorian Eichler, MD

May 19th 2022

The director of the leukodystrophy service at Mass Gen discussed the phase 1/2 study of AXO-AAV-GM2.

Florian Eichler, MD

Articles by Florian Eichler, MD

Florian Eichler, MD, on Addressing Unmet Needs in Canavan Disease With Gene Therapy

Florian Eichler, MD, on Promising Efficacy of AXO-AAV-GM2 in GM2 Gangliosidosis

Florian Eichler, MD, on How Novel Gene Therapy Delivery Improved Targeting in GM2 Gangliosidosis

Latest Updated Articles

Trending on CGTlive®

Sarepta Therapeutics’ Limb-Girdle Muscular Dystrophy Gene Therapy SRP-9003 Produces “Robust Expression” of β-SG in Phase 3 Trial